• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估不同数据集上用于预测蛋白质和肽聚集的计算工具。

Evaluation of in silico tools for the prediction of protein and peptide aggregation on diverse datasets.

机构信息

Indian Institute of Technology Madras, India.

Indian Institute of Technology, Madras, India.

出版信息

Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab240.

DOI:10.1093/bib/bbab240
PMID:34181000
Abstract

Several prediction algorithms and tools have been developed in the last two decades to predict protein and peptide aggregation. These in silico tools aid to predict the aggregation propensity and amyloidogenicity as well as the identification of aggregation-prone regions. Despite the immense interest in the field, it is of prime importance to systematically compare these algorithms for their performance. In this review, we have provided a rigorous performance analysis of nine prediction tools using a variety of assessments. The assessments were carried out on several non-redundant datasets ranging from hexapeptides to protein sequences as well as amyloidogenic antibody light chains to soluble protein sequences. Our analysis reveals the robustness of the current prediction tools and the scope for improvement in their predictive performances. Insights gained from this work provide critical guidance to the scientific community on advantages and limitations of different aggregation prediction methods and make informed decisions about their research needs.

摘要

在过去的二十年中,已经开发出了几种预测算法和工具来预测蛋白质和肽的聚集。这些计算工具有助于预测聚集倾向和淀粉样变性,以及鉴定易于聚集的区域。尽管人们对该领域非常感兴趣,但系统地比较这些算法的性能至关重要。在这篇综述中,我们使用各种评估方法对九种预测工具进行了严格的性能分析。评估是在几个非冗余数据集上进行的,这些数据集范围从六肽到蛋白质序列,以及淀粉样变性抗体轻链到可溶性蛋白质序列。我们的分析揭示了当前预测工具的稳健性,以及提高其预测性能的空间。这项工作提供的见解为科学界提供了关于不同聚集预测方法的优缺点的关键指导,并为他们的研究需求做出明智的决策。

相似文献

1
Evaluation of in silico tools for the prediction of protein and peptide aggregation on diverse datasets.评估不同数据集上用于预测蛋白质和肽聚集的计算工具。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab240.
2
CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation.CPAD,精心整理的蛋白质聚集数据库:一个关于蛋白质和肽聚集的手动整理实验数据的存储库。
PLoS One. 2016 Apr 4;11(4):e0152949. doi: 10.1371/journal.pone.0152949. eCollection 2016.
3
ANuPP: A Versatile Tool to Predict Aggregation Nucleating Regions in Peptides and Proteins.ANuPP:一种用于预测肽和蛋白质中聚集核区域的多功能工具。
J Mol Biol. 2021 May 28;433(11):166707. doi: 10.1016/j.jmb.2020.11.006. Epub 2020 Nov 12.
4
Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.对神经退行性疾病中涉及的淀粉样蛋白可溶性聚集体的自身免疫反应:重叠的易于聚集和自身免疫原性区域。
Sci Rep. 2016 Feb 29;6:22258. doi: 10.1038/srep22258.
5
Identification of properties important to protein aggregation using feature selection.利用特征选择鉴定对蛋白质聚集重要的性质。
BMC Bioinformatics. 2013 Oct 28;14:314. doi: 10.1186/1471-2105-14-314.
6
Exploring the sequence features determining amyloidosis in human antibody light chains.探索决定人抗体轻链淀粉样变性的序列特征。
Sci Rep. 2021 Jul 2;11(1):13785. doi: 10.1038/s41598-021-93019-9.
7
AbsoluRATE: An in-silico method to predict the aggregation kinetics of native proteins.AbsoluRATE:一种预测天然蛋白质聚集动力学的计算方法。
Biochim Biophys Acta Proteins Proteom. 2021 Sep;1869(9):140682. doi: 10.1016/j.bbapap.2021.140682. Epub 2021 Jun 6.
8
A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.用于预测球状蛋白质中“易于聚集”肽的共识方法。
PLoS One. 2013;8(1):e54175. doi: 10.1371/journal.pone.0054175. Epub 2013 Jan 10.
9
Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.拟肽淀粉样蛋白聚集抑制剂:计算模拟、单分子和细胞活力研究。
Int J Mol Sci. 2021 Jan 21;22(3):1051. doi: 10.3390/ijms22031051.
10
Exploiting heterogeneous features to improve in silico prediction of peptide status - amyloidogenic or non-amyloidogenic.挖掘异质特征以提高肽状态(淀粉样变性或非淀粉样变性)的计算预测。
BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S21. doi: 10.1186/1471-2105-12-S13-S21. Epub 2011 Nov 30.

引用本文的文献

1
Investigating Local Sequence-Structural Attributes of Amyloidogenic Light Chain Variable Domains.研究淀粉样轻链可变结构域的局部序列-结构属性
Proteins. 2025 Mar 4. doi: 10.1002/prot.26815.
2
Interpretable molecular encodings and representations for machine learning tasks.用于机器学习任务的可解释分子编码和表示。
Comput Struct Biotechnol J. 2024 May 24;23:2326-2336. doi: 10.1016/j.csbj.2024.05.035. eCollection 2024 Dec.
3
Recombinant multiepitope proteins expressed in Escherichia coli cells and their potential for immunodiagnosis.
在大肠杆菌细胞中表达的重组多表位蛋白及其在免疫诊断中的潜力。
Microb Cell Fact. 2024 May 22;23(1):145. doi: 10.1186/s12934-024-02418-w.
4
Accelerating therapeutic protein design with computational approaches toward the clinical stage.利用计算方法加速治疗性蛋白质设计迈向临床阶段。
Comput Struct Biotechnol J. 2023 Apr 29;21:2909-2926. doi: 10.1016/j.csbj.2023.04.027. eCollection 2023.
5
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics.生物疗法的工业化趋势:89 种基于抗体的生物疗法产品特征调查。
MAbs. 2023 Jan-Dec;15(1):2191301. doi: 10.1080/19420862.2023.2191301.
6
Computationally-Aided Modeling of Hsp70-Client Interactions: Past, Present, and Future.基于计算的 HSP70-客户相互作用建模:过去、现在和未来。
J Phys Chem B. 2022 Sep 15;126(36):6780-6791. doi: 10.1021/acs.jpcb.2c03806. Epub 2022 Aug 30.
7
Prediction of Aggregation of Biologically-Active Peptides with the UNRES Coarse-Grained Model.用 UNRES 粗粒化模型预测生物活性肽的聚集。
Biomolecules. 2022 Aug 18;12(8):1140. doi: 10.3390/biom12081140.
8
AMYPred-FRL is a novel approach for accurate prediction of amyloid proteins by using feature representation learning.AMYPred-FRL 是一种通过使用特征表示学习来准确预测淀粉样蛋白的新方法。
Sci Rep. 2022 May 11;12(1):7697. doi: 10.1038/s41598-022-11897-z.
9
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.基于机器学习的定制化单克隆抗体设计的进展与挑战。
MAbs. 2022 Jan-Dec;14(1):2008790. doi: 10.1080/19420862.2021.2008790.